I-131-MIBG Therapy in metastatic phaeochromocytoma and paraganglioma

Gedik, HATİCE; Hoefnagel, Cornelis; Bais, Evert; Olmos, Renato

doi:10.1007/s00259-007-0652-6

I-131-MIBG Therapy in metastatic phaeochromocytoma and paraganglioma

Gedik G. K., Hoefnagel C. A., Bais E., Olmos R. A. V.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, cilt.35, sa.4, ss.725-733, 2008 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 35 Sayı: 4
Basım Tarihi: 2008
Doi Numarası: 10.1007/s00259-007-0652-6
Dergi Adı: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.725-733
Hacettepe Üniversitesi Adresli: Evet

Özet

Purpose (131)Iodine metaiodobenzylguanidine (I-131-MIBG) is a radiopharmaceutical used for scintigraphic localisation of phaeochromocytomas and paragangliomas. The experience with its therapeutic use is limited. We report our experience for the treatment of malignant phaeochromocytoma and paraganglioma.